2026 BD opportunity scan for Changchun BCHT Biotechnology Co.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ratio

2026 BD opportunity scan for Centre Léon Bérard Lyon et Rhône-Alpes: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach

2026 BD opportunity scan for Cenexi SAS: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Celltrion Pharm Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for CellSight Technologies, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale

2026 BD opportunity scan for CanWell Pharma Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Caliway Biopharmaceuticals Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ra

2026 BD opportunity scan for BrightPath Biotherapeutics Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r

2026 BD opportunity scan for Breathe Biologics Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Brainfarma Indústria Química e Farmacêutica SA: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Biosios (Beijing) Biotechnology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for BioNova Pharmaceuticals (Shanghai) Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreac